The US market is supported by advancements in diagnostic technologies, increasing investments in infectious disease research, and the development of innovative vaccines and medications. Pharmaceutical companies and research institutions are focusing on improving the detection and management of zoonotic infections through advanced therapeutic approaches.
Market Overview
The Zoonotic Disease...